In response to SARS-CoV-2 infection, CD4+ T cells can be detected within 2–4 days of symptom onset, and the abundance of these cells are thought to have the strongest correlation with decreased COVID-19 severity [137]. This evidence concerns the gene CD4 and COVID-19.